By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fitch Ratings has affirmed its ratings on Agilent Technologies' debt and has revised its outlook to 'positive' from 'stable.'

The Chicago-based rating agency affirmed Agilent's Issuer Default Rating of 'BBB,' as well as a 'BBB' rating on the firm's senior unsecured revolving credit facility and its senior unsecured notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.